microRNA 4795 (MIR4795)

microRNA 4795 (MIR4795) is a predicted human microRNA, one of many short (~22 nucleotides), non-coding RNAs that function primarily in post-transcriptional regulation of gene expression by binding to complementary sequences in messenger RNAs, leading to their degradation or translational repression[1][3][5]. Like other microRNAs, its molecular classification is that of a non-coding RNA rather than a receptor, enzyme, or protein target. There is no established evidence that MIR4795 plays a direct or characterized role in specific biological pathways, disease mechanisms, or therapeutic response. As of the latest major miRNA database releases and scientific literature, no well-curated functional studies, disease associations, or drug interactions have been published for MIR4795. Important note: - MIR4795/hsa-mir-4795 is a predicted or poorly characterized microRNA with almost no experimental data on biological function, disease relevance, or druggability in the mainstream literature, miRBase, or comprehensive miRNA-specific reviews[5]. - microRNAs as a class are not proteins, receptors, or direct drug targets in the traditional sense and are handled differently from standard protein targets[1][3][5]. If you are seeking information on a more established or clinically relevant microRNA, please review the name and context, as "MIR4795" does not appear in validated human miRNA function or clinical studies. Summary classification: - Not a therapeutic target - Insufficient data and not recognized as a functionally characterized or clinically actionable molecule - Likely a prediction or annotation without curated biological evidence

Other names

hsa-mir-4795MIR4795